newsio aggregates and links to original sources. We do not own the original images or content. If you believe content infringes on intellectual property rights, contact us — it will be removed at first notice.

biotech / news / / MarketScreener

Swiss pharmaceutical giant Roche said on Thursday it had agreed to acquire U.S.-based digital pathology and AI-powered technology firm PathAI.

Roche will acquire PathAI for $750 million upfront plus up to $300 million in milestone payments.

KEY POINTS
COMPANIES
Read the full story on MarketScreener →
Share X LinkedIn

Summarized by Newsio from MarketScreener. How we summarize →